Background: One of the risk factors of congestive heart failure that still under investigations is hyperuricemia. It’s still
debatable whether it’s an independent risk factor or it’s just a consequence of
other disorders associated with cardiovascular diseases like hypertension,
diabetes and dyslipidemia. Objective: The
aim of our study is to elucidate whether in patients with heart failure serum
uric acid level correlates with left ventricular ejection fraction supporting
the possibility that the detection of progressive hyperuricemia in these
patients may be an indicator of deteriorating cardiac function. Methods: We
conducted a prospective study that included 124 studied patients and 26
apparently healthy persons at Coronary care unit and Internal Medicine
Department at Sohag University Hospitals. Studied populations were classified
into; * Group “I”: newly diagnosed heart failure, * Group “II”: decompensated
heart failure on regular treatment, * Group “III”: decompensated heart failure
but stopped their treatment from three months, Group “IV”: control group,
healthy and age-matched subjects. We studied the association between left
ventricular ejection fraction, the severity of congestive heart failure and the
serum uric acid levels and the well-known conventional risk factors. Results: The main finding was the significantly higher
mean serum uric acid levels in patients with congestive heart failure versus
apparently healthy persons with “P value = 0
References
[1]
McMurray, J.J.V., Cherubini, A., Ble, A., Bos, A.J.G., Maggio, M., Dixit, V.D., et al. (2014) Uric Acid and Inflammatory Markers. European Heart Journal, 27, 1174-1181. https://doi.org/10.1093/eurheartj/ehi879
Adamopoulos, S., Anker, S.D., Auricchio, A., Bohm, M., Dickstein, K., et al. (2012) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 33, 1787-1847.
[4]
Fang, J. and Alderman, M.H. (2015) Serum Uric Acid and Cardiovascular Mortality the NHANES I Epidemiologic Follow-Up Study 1971-1992. National Health and Nu-trition Examination Survey.
[5]
Dickstein, K., Krishnan, E., Chen, L. and Schumacher, H.R. (2012) Serum Uric Acid and Cardiovascular Disease: Recent Developments, and Where Do They Leave Us. The American Journal of Medicine, 118, 816-826. https://doi.org/10.1016/j.amjmed.2005.03.043
[6]
Leyva, F., Anker, S.D., Godsland, I.F., Teixeira, M., Hellewell, P.G., Kox, W.J., et al. (1998) Uric acid in Chronic Heart Failure: A Marker of Chronic Inflammation. Euro-pean Heart Journal, 19, 1814-1822. https://doi.org/10.1053/euhj.1998.1188
[7]
Lotan, C., Benjamin, E.J., Go, A.S., Arnett, D.K., Blaha, M.J., Cushman, M., et al. (2015) Heart Disease and Stroke Statistics 2015 Update: A Report from the American Heart Association. Circulation, 131, e29-322.
[8]
Harzand, A., Palacio, A., Verma, S., Jones, J., Hare, J., et al. (2016) Uric Acid as a Predictor of All-Cause Mortality in Heart Failure: A Meta-Analysis. Congestive Heart Failure, 17, 25-30. https://doi.org/10.1111/j.1751-7133.2011.00200.x
[9]
Deveci, T., Takeishi, Y., Arimoto, T., Okuyama, H., Nozaki, N., Hirono, O., et al. (2013) Hyperuricemia Associated with High Cardiac Event Rates in the Elderly with Chronic Heart Failure. Journal of Cardiology, 47, 219-228.
[10]
Sun, T., Furumoto, T., Tsuchihashi-Makaya, M., Goto, K., Goto, D., Yokota, T., et al. (2014) Hyperuricemia Predicts Adverse Outcomes in Patients with Heart Failure. In-ternational Journal of Cardiology, 151, 143-147.
[11]
Gotsman, I., Keren, A., Lotan, C. and Zwas, D.R. (2012) Changes in Uric Acid Levels and Allopurinol Use in Chronic Heart Failure: Association with Improved Survival. Journal of Cardiac Failure, 18, 694-701. https://doi.org/10.1016/j.cardfail.2012.06.528
[12]
Deveci, O.S., Kabakci, G., Okutucu, S., Tulumen, E., et al. (2010) The Association between Serum Uric Acid Level and Coronary Artery Disease. Clin Pract, 64, 900–907.
[13]
Coutinho Tde, A., Turner, S.T., Peyser, P.A., Bielak, L.F., Sheedy, P.F. and Kullo, I.J. (2007) Associations of Serum Uric Acid with Markers of Inflammation, Metabolic Syndrome, and Subclinical Coronary Atherosclerosis. American Journal of Hyperten-sion, 20, 83-89. https://doi.org/10.1016/j.amjhyper.2006.06.015
[14]
Doehner, W. and Anker, S.D. (2005) Uric Acid in Chronic Heart Failure. Seminars in Nephrology, 25, 61-66. https://doi.org/10.1016/j.semnephrol.2004.09.010
